Soler-Cataluña Juan José, Sánchez-Sánchez Lourdes, Martínez-García Miguel Angel, Sánchez Pilar Román, Salcedo Emmanuel, Navarro Miriam
Unidad de Neumologyía, Servicio de Medicina Interna, Hospital General de Requena, Paraje Casablanca s/n, 46340 Requena, Valencia, Spain. soler
Chest. 2005 Oct;128(4):2108-15. doi: 10.1378/chest.128.4.2108.
A low body mass index (BMI) has been shown to be an independent indicator of poor prognosis in patients with COPD. However, some studies suggest that muscle mass depletion (MD) is the main factor responsible for the negative effects attributable to malnutrition.
To evaluate the prognostic influence of MD estimated from anthropometric parameters.
Mortality was studied in a prospective cohort of 96 male patients with COPD (average age, 69 +/- 9 years; FEV1 percentage of predicted, 44 +/- 18% [ +/- SD]) followed up for 3 years, with an evaluation of the prognostic influence of the following anthropometric parameters: BMI, mid-arm muscle area (MAMA), and fat-free mass index. Other risk factors were also analyzed, such as age, comorbidity (Charlson index), basal dyspnea index, the St. George's Respiratory Questionnaire score, the number of hospital admissions in the year prior to nutritional evaluation, the number of hospital admissions in the year immediately after nutritional evaluation (Hpost), spirometry, and blood gases.
In the multivariate study, Pa(CO2) (p = 0.003; hazard ratio, 1.08), Hpost (p = 0.005, hazard ratio, 4.63), and a MAMA value less than or equal to percentile 25 of the reference value (p25) [p = 0.025; hazard ratio, 3.78] were found to be independent indicators of poor prognosis. Respiratory mortality after 12, 24, and 36 months in the patients with MAMA < or = p25 was 12.1%, 31.4%, and 39.2%, respectively, vs 5.9%, 7.9%, and 13% in the group of patients without MD (p = 0.006). In normal-weight or overweight patients, MAMA < or = p25 increased the risk of mortality 3.4-fold (p = 0.032).
MD is a better predictor of mortality than BMI in patients with COPD, fundamentally in normal-weight or overweight patients. The prognostic influence of MD can be estimated indirectly by determining the MAMA, an inexpensive, simple, and rapidly obtained anthropometric measure.
低体重指数(BMI)已被证明是慢性阻塞性肺疾病(COPD)患者预后不良的独立指标。然而,一些研究表明,肌肉量减少(MD)是营养不良所致负面影响的主要因素。
评估通过人体测量参数估算的MD的预后影响。
对96例男性COPD患者(平均年龄69±9岁;预计第一秒用力呼气容积百分比为44±18%[±标准差])进行前瞻性队列研究,随访3年,评估以下人体测量参数的预后影响:BMI、上臂中部肌肉面积(MAMA)和去脂体重指数。还分析了其他风险因素,如年龄、合并症(查尔森指数)、基础呼吸困难指数、圣乔治呼吸问卷评分、营养评估前一年的住院次数、营养评估后紧接着一年的住院次数(Hpost)、肺功能测定和血气分析。
在多变量研究中,发现动脉血二氧化碳分压(Pa(CO2))(p = 0.003;风险比,1.08)、Hpost(p = 0.005,风险比,4.63)以及MAMA值小于或等于参考值第25百分位数(p25)[p = 0.025;风险比,3.78]是预后不良的独立指标。MAMA≤p25的患者在12个月、24个月和36个月后的呼吸死亡率分别为12.1%、31.4%和39.2%,而无MD的患者组分别为5.9%﹑7.9%和13%(p = 0.006)。在体重正常或超重的患者中,MAMA≤p25使死亡风险增加3.4倍(p = 0.032)。
在COPD患者中,尤其是体重正常或超重的患者,MD比BMI是更好的死亡率预测指标。通过测定MAMA可间接估算MD的预后影响,MAMA是一种廉价、简单且能快速获取的人体测量指标。